Seattle Genetics Win Early US FDA Approval For Tukysa, Plans Rapid Launch

 
• By Mandy Jackson
FDA Approved typed words on a vintage typewriter
Tukysa was approved for second-line or later HER2-positive breast cancer

More from New Products

More from Scrip